Evidence map›Paper›PMID 25642274›Full record

ArticlePersonalized medicine

'Someday it will be the norm': physician perspectives on the utility of genome sequencing for patient care in the MedSeq Project.

Jason L Vassy, Kurt D Christensen, Melody J Slashinski, Denise M Lautenbach, Sridharan Raghavan, Jill Oliver Robinson, Jennifer Blumenthal-Barby, Lindsay Zausmer Feuerman, Lisa Soleymani Lehmann, Michael F Murray and 2 more

2 registry-linked trialsAbstract read
In one paragraph

Article in Personalized medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03276637 nacompletednot on this map

The MilSeq Project: Enabling Personalized Medicine Through Exome Sequencing in the U.S. Air Force

TypeinterventionalSponsorBrigham and Women's HospitalRan2017 to 2020Enrolled105ConditionsHealthy Adults, Genetic Predisposition to DiseaseArmsWhole exome sequencing
NCT04331535 naunknown statusnot on this map

Pragmatic Randomized Trial of Polygenic Risk Scoring for Common Diseases in Primary Care

TypeinterventionalSponsorBoston VA Research Institute, Inc.Ran2020 to 2025Enrolled1,076ConditionsCoronary Artery Disease, Atrial Fibrillation, Type 2 Diabetes, Colorectal CancerArmsPolygenic risk score (PRS)
3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. The Future of Newborn Genomic Testing.Children (Basel, Switzerland) · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jason L VassySection of General Internal Medicine, VA Boston Healthcare System, Boston, MA 02130, USA ; Division of General Medicine & Primary Care, Department of Medicine, Brigham & Women's Hospital, Boston, MA 02115, USA ; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
Kurt D ChristensenDepartment of Medicine, Harvard Medical School, Boston, MA 02115, USA ; Division of Genetics, Brigham & Women's Hospital, Boston, MA 02115, USA.
Melody J SlashinskiSchool of Public Health & Health Sciences, University of Massachusetts, Amherst, MA 01003, USA.
Denise M LautenbachDepartment of Medicine, Harvard Medical School, Boston, MA 02115, USA ; Division of Genetics, Brigham & Women's Hospital, Boston, MA 02115, USA.
Sridharan RaghavanDepartment of Medicine, Harvard Medical School, Boston, MA 02115, USA ; General Medicine Division, Massachusetts General Hospital, Boston, MA 02114, USA.
Jill Oliver RobinsonCenter for Medical Ethics & Health Policy, Baylor College of Medicine, Houston, TX 77030, USA.
Jennifer Blumenthal-BarbyCenter for Medical Ethics & Health Policy, Baylor College of Medicine, Houston, TX 77030, USA.
Lindsay Zausmer FeuermanCenter for Medical Ethics & Health Policy, Baylor College of Medicine, Houston, TX 77030, USA.
Lisa Soleymani LehmannDivision of General Medicine & Primary Care, Department of Medicine, Brigham & Women's Hospital, Boston, MA 02115, USA ; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA ; General Medicine Division, Massachusetts General Hospital, Boston, MA 02114, USA.
Michael F MurrayGeisinger Health System, Danville, PA 17822 4910, USA.
Robert C GreenDepartment of Medicine, Harvard Medical School, Boston, MA 02115, USA ; Division of Genetics, Brigham & Women's Hospital, Boston, MA 02115, USA.
Amy L McGuireCenter for Medical Ethics & Health Policy, Baylor College of Medicine, Houston, TX 77030, USA.

Funding

HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
Integration of Whole Genome Sequencing into Clinical MedicineU01HG006500 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI GREEN, ROBERT C. · 2012 to 2016
$11.5M
Genome Sequence-Based Screening for Childhood Risk and Newborn IllnessU19HD077671 · NICHD · BRIGHAM AND WOMEN'S HOSPITAL · PI BEGGS, ALAN H., GREEN, ROBERT C. · 2013 to 2018
$6.1M
Incidental Finding Preferences in Whole Genome Sequencing: A Randomized TrialF32HG006993 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI CHRISTENSEN, KURT DEREK · 2012 to 2013
$102k
NCRR NIH HHS UL1 RR025758NHGRI NIH HHS F32 HG006993NHGRI NIH HHS U01 HG006500NICHD NIH HHS U19 HD077671NIDDK NIH HHS L30 DK089597
6 · The paper itself

Abstract

aimTo describe practicing physicians' perceived clinical utility of genome sequencing. MATERIALS &

methodsWe conducted a mixed-methods analysis of data from 18 primary care physicians and cardiologists in a study of the clinical integration of whole-genome sequencing. Physicians underwent brief genomics continuing medical education before completing surveys and semi-structured interviews.

resultsPhysicians described sequencing as currently lacking clinical utility because of its uncertain interpretation and limited impact on clinical decision-making, but they expressed the idea that its clinical integration was inevitable. Potential clinical uses for sequencing included complementing other clinical information, risk stratification, motivating patient behavior change and pharmacogenetics.

conclusionPhysicians given genomics continuing medical education use the language of both evidence-based and personalized medicine in describing the utility of genome-wide testing in patient care.

Indexed as

genomicshigh-throughput nucleotide sequencingpharmacogeneticsphysician’s practice patternsqualitative research

Identifiers

PMID25642274
PMCPMC4306284

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.